Global Cardiovascular Risk Profile and Cerebrovascular Abnormalities in Presymptomatic Individuals with CADASIL or Autosomal Dominant Alzheimer’s Disease
Tóm tắt
Background: Cardiovascular risk factors increase the risk of developing dementia, including Alzheimer’s disease and vascular dementia. Objective: Studying individuals with autosomal dominant mutations leading to the early onset of dementia, this study examines the effect of the global cardiovascular risk profile on early cognitive and neuroimaging features of Alzheimer’s disease and vascular dementia. Methods: We studied 85 non-demented and stroke-free individuals, including 20 subjects with Presenilin1 (PSEN1) E280A mutation leading to the early onset of autosomal dominant Alzheimer’s disease (ADAD), 20 subjects with NOTCH3 mutations leading to cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and to the early onset of vascular dementia, and 45 non-affected family members (non-carriers). All subjects underwent clinical and neuropsychological evaluations and an MRI. The global cardiovascular risk profile was estimated using the office-based Framingham Cardiovascular Risk Profile (FCRP) score. Results: In individuals with CADASIL, a higher FCRP score was associated with a reduced hippocampal volume (B = –0.06, p < 0.05) and an increased severity of cerebral microbleeds (B = 0.13, p < 0.001), lacunes (B = 0.30, p < 0.001), and perivascular space enlargement in the basal ganglia (B = 0.50, p < 0.05). There was no significant association between the FCRP score and neuroimaging measures in ADAD or non-carrier subjects. While the FCRP score was related to performance in executive function in non-carrier subjects (B = 0.06, p < 0.05), it was not significantly associated with cognitive performance in individuals with CADASIL or ADAD. Conclusion: Our results suggest that individuals with CADASIL and other forms of vascular cognitive impairment might particularly benefit from early interventions aimed at controlling cardiovascular risks.
Từ khóa
Tài liệu tham khảo
Abraham, 2016, Cardiovascular risk factors and small vessel disease of the brain: Blood pressure, white matter lesions, and functional decline in older persons, J Cereb Blood Flow Metab, 36, 132, 10.1038/jcbfm.2015.121
Seo, 2012, Cardiovascular risk factors cause cortical thinning in cognitively impaired patients: Relationships among cardiovascular risk factors, white matter hyperintensities, and cortical atrophy, Alzheimer Dis Assoc Disord, 26, 106, 10.1097/WAD.0b013e31822e0831
van Dijk, 2004, The association between blood pressure, hypertension, and cerebral white matter lesions: Cardiovascular determinants of dementia study, Hypertension, 44, 625, 10.1161/01.HYP.0000145857.98904.20
Den Heijer, 2005, Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe, Neurology, 64, 263, 10.1212/01.WNL.0000149641.55751.2E
Sahathevan, 2012, Dementia, stroke, and vascular risk factors; a review, Int J Stroke, 7, 61, 10.1111/j.1747-4949.2011.00731.x
Gorelick, 2004, Risk factors for vascular dementia and Alzheimer disease, Stroke, 35, 2620, 10.1161/01.STR.0000143318.70292.47
Kaffashian, 2013, Predicting cognitive decline: A dementia risk score vs the Framingham vascular risk scores, Neurology, 80, 1300, 10.1212/WNL.0b013e31828ab370
Grodstein, 2007, Cardiovascular risk factors and cognitive function, Alzheimers Dement, 3, S16, 10.1016/j.jalz.2007.01.001
Dregan, 2013, Cardiovascular risk factors and cognitive decline in adults aged 50 and over: A population-based cohort study, Age Ageing, 42, 338, 10.1093/ageing/afs166
Lo, 2012, Vascular burden and Alzheimer disease pathologic progression, Neurology, 79, 1349, 10.1212/WNL.0b013e31826c1b9d
Baumgart, 2015, Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective, Alzheimers Dement, 11, 718, 10.1016/j.jalz.2015.05.016
Jellinger, 2010, Prevalence of dementia disorders in the oldest-old: An autopsy study, Acta Neuropathol, 119, 421, 10.1007/s00401-010-0654-5
Newman, 2005, Dementia and Alzheimer’s disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort, J Am Geriatr Soc, 53, 1101, 10.1111/j.1532-5415.2005.53360.x
Attems, 2014, The overlap between vascular disease and Alzheimer’s disease-lessons from pathology, BMC Med, 12, 1, 10.1186/s12916-014-0206-2
Joutel, 1996, Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia, Nature, 383, 707, 10.1038/383707a0
Ikram, 2017, Genetics of vascular dementia–review from the ICVD working group, BMC Med, 15, 48, 10.1186/s12916-017-0813-9
Nannucci, 2015, Clinical, familial, and neuroimaging features of CADASIL-like patients, Acta Neurol Scand, 131, 30, 10.1111/ane.12284
Schoemaker, 2019, Clinical and research applications of magnetic resonance imaging in the study of CADASIL, Neurosci Lett, 698, 173, 10.1016/j.neulet.2019.01.014
Stojanov, 2015, Imaging characteristics of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL), Bosn J Basic Med Sci, 15, 1, 10.17305/bjbms.2015.247
O’Sullivan, 2009, Hippocampal volume is an independent predictor of cognitive performance in CADASIL, Neurobiol Aging, 30, 890, 10.1016/j.neurobiolaging.2007.09.002
Charlton, 2006, The cognitive profiles of CADASIL and sporadic small vessel disease, Neurology, 66, 1523, 10.1212/01.wnl.0000216270.02610.7e
Amberla, 2004, Insidious cognitive decline in CADASIL, Stroke, 35, 1598, 10.1161/01.STR.0000129787.92085.0a
Taillia, 1998, Cognitive alterations in non-demented CADASIL patients, Cerebrovasc Dis, 8, 97, 10.1159/000015825
Ryman, 2014, Symptom onset in autosomal dominant Alzheimer disease: A systematic review and meta-analysis, Neurology, 83, 253, 10.1212/WNL.0000000000000596
Aguirre-Acevedo, 2016, Cognitive decline in a Colombian kindred with autosomal dominant Alzheimer disease: A retrospective cohort study, JAMA Neurol, 73, 431, 10.1001/jamaneurol.2015.4851
Fuller, 2019, Biological and cognitive markers of presenilin1 E280A autosomal dominant Alzheimer’s disease: A comprehensive review of the Colombian kindred, J Prev Alzheimers Dis, 6, 112
Lee, 2016, White matter hyperintensities are a core feature of Alzheimer’s disease: Evidence from the dominantly inherited Alzheimer network, Ann Neurol, 79, 929, 10.1002/ana.24647
Ringman, 2016, Neuropathology of autosomal dominant Alzheimer disease in the National Alzheimer Coordinating Center database, J Neuropathol Exp Neurol, 75, 284, 10.1093/jnen/nlv028
Gómez-Isla, 1999, The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer’s disease brain: Evidence for otherhenotype-modifying factors, Brain, 122, 1709, 10.1093/brain/122.9.1709
Bateman, 2011, Autosomal-dominant Alzheimer’s disease: A review and proposal for the prevention of Alzheimer’s disease, Alzheimers Res Ther, 3, 1, 10.1186/alzrt59
Sclan, 1992, Functional assessment staging (FAST) in Alzheimer’s disease: Reliability, validity, and ordinality, Int Psychogeriatr, 4, 55, 10.1017/S1041610292001157
Acosta-Baena, 2011, Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer’s disease: A retrospective cohort study, Lancet Neurol, 10, 213, 10.1016/S1474-4422(10)70323-9
Zuluaga-Castaño, 2018, Cognitive performance in asymptomatic carriers of mutations R1031C and R141C in CADASIL, Int J Psychol Res, 11, 46
D’Agostino, 2008, General cardiovascular risk profile for use in primary care, Circulation, 117, 743, 10.1161/CIRCULATIONAHA.107.699579
Gaziano, 2008, Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: The NHANES I Follow-up Study cohort, Lancet, 371, 923, 10.1016/S0140-6736(08)60418-3
D’Agostino, 2013, Cardiovascular disease risk assessment: Insights from Framingham, Glob Heart, 8, 11, 10.1016/j.gheart.2013.01.001
Damen, 2019, Performance of the Framingham risk models and pooled cohort equations for predicting 10-year risk of cardiovascular disease: A systematic review and meta-analysis, BMC Med, 17, 1, 10.1186/s12916-019-1340-7
D’Agostino, 2008, General cardiovascular risk profile for use in primary care: The Framingham Heart Study, Circulation, 17, 743, 10.1161/CIRCULATIONAHA.107.699579
Folstein, 1983, The mini-mental state examination, Arch Gen Psychiatry, 40, 812, 10.1001/archpsyc.1983.01790060110016
Welsh, 1994, The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part V. A normative study of the neuropsychological battery, Neurology, 44, 609, 10.1212/WNL.44.4.609
Chandler, 2005, A total score for the CERAD neuropsychological battery, Neurology, 65, 102, 10.1212/01.wnl.0000167607.63000.38
Aguirre-Acevedo, 2007, Validity and reliability of the CERAD-Col neuropsychological battery, Rev Neurol, 45, 655
Tombaugh, 2004, Trail Making Test A and B: Normative data stratified by age and education, Arch Clin Neuropsychol, 19, 203, 10.1016/S0887-6177(03)00039-8
Tombaugh, 1999, Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming, Arch Clin Neuropsychol, 14, 167
Potter G , Morris Z , Wardlaw J (2015) Enlarged perivascular spaces (EPVS): A visual rating scale and user guide. The University of Edinburgh, Edinburgh.
Wardlaw, 2014, Vascular risk factors, large-artery atheroma, and brain white matter hyperintensities, Neurology, 82, 1331, 10.1212/WNL.0000000000000312
Fischl, 2002, Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain, Neuron, 33, 341, 10.1016/S0896-6273(02)00569-X
Fischl, 2004, Automatically parcellating the human cerebral cortex, Cereb Cortex, 14, 11, 10.1093/cercor/bhg087
Fazekas, 1987, MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging, AJR Am J Roentgenol, 149, 351, 10.2214/ajr.149.2.351
Yilmaz, 2018, practical small vessel disease score relates to stroke, dementia, and death: The Rotterdam Study, Stroke, 49, 2857, 10.1161/STROKEAHA.118.022485
Staals, 2015, Total MRI load of cerebral small vessel disease and cognitive ability in older people, Neurobiol Aging, 36, 2806, 10.1016/j.neurobiolaging.2015.06.024
McFadden D (1977) Quantitative methods for analyzing travel behavior of individuals: Some recent developments. Institute of Transportation Studies, Berkeley.
Wardlaw, 2013, Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration, Lancet Neurol, 12, 822, 10.1016/S1474-4422(13)70124-8
Lee, 2018, White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer’s disease, PloS One, 13, e0195838, 10.1371/journal.pone.0195838
Ryan, 2012, Cerebral microbleeds in familial Alzheimer’s disease, Brain, 135, e201, 10.1093/brain/awr126
Ryan, 2015, Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer’s disease, Neurobiol Aging, 36, 3140, 10.1016/j.neurobiolaging.2015.08.026
Schoemaker, 2020, The INECO Frontal Screening for the evaluation of executive dysfunction in cerebral small vessel disease: Evidence from quantitative MRI in a CADASIL cohort from Colombia, J Int Neuropsychol Soc, 26, 1006, 10.1017/S1355617720000533
Jouvent, 2008, Cortical changes in cerebral small vessel diseases: A 3D MRI study of cortical morphology in CADASIL, Brain, 131, 2201, 10.1093/brain/awn129
Jouvent, 2007, Brain atrophy is related to lacunar lesions and tissue microstructural changes in CADASIL, Stroke, 38, 1786, 10.1161/STROKEAHA.106.478263
Peters, 2006, Brain volume changes in CADASIL: A serial MRI study in pure subcortical ischemic vascular disease, Neurology, 66, 1517, 10.1212/01.wnl.0000216271.96364.50
Fox, 1998, Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer’s disease. A longitudinal prospective study, Brain, 121, 1631, 10.1093/brain/121.9.1631
Holtmannspotter, 2005, Diffusion magnetic resonance histograms as a surrogate marker and predictor of disease progression in CADASIL: A two-year follow-up study, Stroke, 36, 2559, 10.1161/01.STR.0000189696.70989.a4
Adib-Samii, 2010, Clinical spectrum of CADASIL and the effect of cardiovascular risk factors on phenotype: Study in 200 consecutively recruited individuals, Stroke, 41, 630, 10.1161/STROKEAHA.109.568402
Singhal, 2004, The influence of genetic and cardiovascular risk factors on the CADASIL phenotype, Brain, 127, 2031, 10.1093/brain/awh223
Viswanathan, 2006, Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: A two-centre cohort study, Brain, 129, 2375, 10.1093/brain/awl177
Yao, 2012, Extensive white matter hyperintensities may increase brain volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy, Stroke, 43, 3252, 10.1161/STROKEAHA.112.664854
Nishtala, 2014, Midlife cardiovascular risk impacts executive function: Framingham offspring study, Alzheimer Dis Assoc Disord, 28, 16, 10.1097/WAD.0b013e3182a715bc
Chuang, 2014, Cardiovascular risks and brain function: A functional magnetic resonance imaging study of executive function in older adults, Neurobiol Aging, 35, 1396, 10.1016/j.neurobiolaging.2013.12.008
Vicario, 2005, Hypertension and cognitive decline: Impact on executive function, J Clin Hypertens, 7, 598, 10.1111/j.1524-6175.2005.04498.x
Yaffe, 2014, Early adult to midlife cardiovascular risk factors and cognitive function, Circulation, 129, 1560, 10.1161/CIRCULATIONAHA.113.004798
Badran, 2019, Framingham vascular age is associated with worse cognitive performance in the middle-aged and elderly, Aging Neuropsychol Cogn, 26, 531, 10.1080/13825585.2018.1499866
Carmelli, 1999, Midlife cardiovascular risk factors and brain morphology in identical older male twins, Neurology, 52, 1119, 10.1212/WNL.52.6.1119
Veldsman, 2020, Cerebrovascular risk factors impact frontoparietal network integrity and executive function in healthy ageing, Nat Commun, 11, 1, 10.1038/s41467-020-18201-5
de La Torre, 2012, Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia, Cardiovasc Psychiatry Neurol, 2012, 1, 10.1155/2012/367516